Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01805687 · ClinicalTrials.gov registry record · Phase 4
Single Dose Bronchodilatory Study in Asthma
A Phase 4 study of Asthma, sponsored by Cornerstone Therapeutics.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT01805687: Completed Phase 4 study of Asthma, sponsored by Cornerstone Therapeutics.
NCT01805687 is a Phase 4 study of Asthma that has completed, run by Cornerstone Therapeutics. The registered enrollment target is 25 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01805687, a Phase 4 study of Asthma, has completed, sponsored by Cornerstone Therapeutics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Study to evaluate the bronchodilator effects of Zyflo CR in patients with chronic stable asthma.
Conditions Studied
Interventions
- DRUG Zileuton extended release
Study Locations (1)
Massachusetts
- Northeast Medical Research Associates - North Dartmouth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-03 |
| Phase | Phase 4 |
What the finished NCT01805687 record still lists
NCT01805687 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Zileuton extended release is the first listed.
NCT01805687 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01805687 about?
NCT01805687 is a clinical study titled "Single Dose Bronchodilatory Study in Asthma". Study to evaluate the bronchodilator effects of Zyflo CR in patients with chronic stable asthma.
What is the current status of trial NCT01805687?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2013-03.
What conditions does trial NCT01805687 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT01805687?
The interventions under investigation include: Zileuton extended release (DRUG).
Who is sponsoring clinical trial NCT01805687?
This trial is sponsored by Cornerstone Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01805687 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01805687's enrollment target sits among peer trials
25 318th of 374 higher than 50 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
-
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 4
-
Viral Infection in Asthma (VIA) Study
RECRUITING · Phase 4
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
RECRUITING · Phase 4
-
The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
RECRUITING · Phase 4
-
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia